Compare RNXT & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNXT | CLIR |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 33.3M |
| IPO Year | 2021 | 2011 |
| Metric | RNXT | CLIR |
|---|---|---|
| Price | $0.82 | $4.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.25 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 263.2K | 15.0K |
| Earning Date | 05-14-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,123,000.00 | $530,000.00 |
| Revenue This Year | $194.66 | $34.29 |
| Revenue Next Year | $279.78 | $67.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $0.39 |
| 52 Week High | $1.45 | $7.56 |
| Indicator | RNXT | CLIR |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 49.69 |
| Support Level | $0.81 | $0.58 |
| Resistance Level | $1.07 | $7.56 |
| Average True Range (ATR) | 0.05 | 0.38 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 11.42 | 42.03 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
ClearSign Technologies Corp is engaged in designing and develop technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial combustion systems, including emission and operational performance, energy efficiency and overall cost-effectiveness. Its ClearSign Core technology has been proved to be in full scale industrial test furnaces and boilers and first customer installations are currently operating in normal commercial applications The company offers products that include process burners, boiler burners, flares, and ClearSign Eye. The company operates in one segment: Combustion segment. The products of the company include: Process Burners, Midstream and Power, Flares, Boiler Burners, and Sensing Technology.